Key points The weight loss induced by glucagon-like peptide receptor 1 agonists (GLP1RAs) should reduce the risk of some malignancies, although stimulation of GLP1 receptors might have either detrimental or beneficial direct effects on cancer risk
Vinicius Cruzat, Marcelo Macedo Rogero, Kevin Noel Keane, Rui Curi, Philip Newsholme (2018 Oct) Glutamine: Metabolism and Immune Function, Supplementation and Clinical Translation
They will also consider other options, such as tirzepatide, or oral formats if they better suit your lifestyle
Stack-oriented biohackers
This is a secondary effect of overall matrix improvement, not a direct pore-targeting action
nasca, c., xenos, d., barone, y., caruso, a., scaccianoce, s., & matrisciano, f